News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

PHARMAC welcomes increased budget for 2006 year

PHARMAC welcomes increased budget for 2006 year

PHARMAC Chief Executive Wayne McNee has welcomed the approval of an increase in government pharmaceutical funding for the 2006 financial year.

The Minister of Health has today announced that the pharmaceutical budget for 2005-06 will be $582.86 million, a 3.2 percent increase on the 2005 budget figure. This includes $3 million of funding as part of the cancer control strategy.

The figure announced today is an increase on that included in the three-year funding path, to take into account the impact of government policies such as the rollout of low-cost PHOs, and the increased cost of new medicines.

Wayne McNee says the increased budget will give PHARMAC further scope for spending on more new medicines for New Zealand patients.

“Over the past two years it has been pleasing to be able to focus on subsidising over 20 new medicines and widening access to others, and the increase in the budget means this spending can continue,” Wayne McNee says. “This is good news for patients, for PHARMAC and for the pharmaceutical industry in New Zealand.”

New medicines funded in the past year include ezetimibe for raised cholesterol; tiotropium for chronic obstructive pulmonary disease; fentanyl for chronic pain and a combination HIV/AIDS medicine, Kaletra. Access was also widened to medicines including letrozole for breast cancer; candesartan for blood pressure management; olanzapine for mental illness; and pegylated interferon for hepatitis B.

This list has continued to grow in the current financial year with PHARMAC already announcing decisions relating to the pain relievers oxycodone and gabapentin, and breast cancer drugs.

“This increase in funding will make it possible to fund more subsidised medicines for New Zealanders. It is essential that we have ongoing increases in expenditure in order to meet the health needs of New Zealanders,” Wayne McNee says. “We are continuing to work with DHBs to finalise our funding path for future years, in order that we can continue to plan effectively for the future.”

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland